Purchases and Sales Made in Q2 2024 in Merrimack Pharmaceuticals Inc (MACK)
This table provides information about the institutional ownership of Merrimack Pharmaceuticals Inc (MACK) during Q2 2024. The information is specifically focused on institutions that hold shares of MERRIMACK PHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 08, 2024
Q2 2024
|
Jbf Capital, Inc.
Aspen, CO |
BUY
|
- |
39.6KNew |
$582K - $600K
|
39.6K
$600K
|
|
|
Aug 14, 2024
Q2 2024
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
38.2KNew |
$561K - $578K
|
38.2K
$578K
|
|
|
Aug 13, 2024
Q2 2024
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
15.3K+ 105.98% |
$225K - $232K
|
29.8K
$451K
|
|
|
Jul 22, 2024
Q2 2024
|
Caldwell Sutter Capital, Inc.
Sausalito, CA |
BUY
|
- |
7.46KNew |
$109K - $113K
|
7.46K
$113K
|
|
|
Jul 31, 2024
Q2 2024
|
Farther Finance Advisors, LLC
San Francisco, CA |
BUY
|
- |
77New |
$1.13K - $1.17K
|
77
$1.17K
|
|
|
Jul 09, 2024
Q2 2024
|
Cwm, LLC
|
BUY
|
- |
17+ 340.0% |
$250 - $257
|
22
$333
|
|
|
Aug 01, 2024
Q2 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-11K- 81.66% |
$162K - $167K
|
2.48K
$37.5K
|
|
|
Aug 09, 2024
Q2 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-79K- 19.85% |
$1.16M - $1.2M
|
319K
$4.83M
|